![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
N Sakai, S Kaufman and S Milstein
Laboratory of Neurochemistry, National Institute of Mental Health, Bethesda, Maryland 20892.
The murine macrophage cell line RAW 264 constitutively synthesizes tetrahydrobiopterin (BH4), the cofactor required for the hydroxylation of the aromatic amino acids and for the production of nitric oxide. Stimulation of the cells with interferon-gamma and lipopolysaccharide induced the production of nitric oxide and increased BH4 levels further. When the cells were stimulated in the presence of 2,4-diamino- 6-hydroxypyrimidine (DAHP), an inhibitor of BH4 biosynthesis, biopterin levels decreased by 90% within 6 hr, whereas nitrite production was essentially unaffected. Pretreatment of the cells for 12 hr with DAHP decreased intracellular BH4 concentrations by > 95% yet inhibited the cytokine-stimulated production of nitric oxide by only 50%. However, pretreatment with DAHP plus N-acetylserotonin, an inhibitor of sepiapterin reductase, the terminal enzyme of the BH4 biosynthetic pathway, decreased biopterin levels by > 99% and inhibited nitric oxide synthesis by 90%. This inhibition could be reversed by loading the cells with dihydrobiopterin, a precursor of BH4 via the dihydrofolate reductase salvage pathway. In addition, these studies revealed that N- acetylserotonin has a direct inhibitory effect on nitric oxide synthesis, acting in a BH4-independent manner. The results presented here support previous suggestions, based on experiments with isolated enzymes, that BH4 is absolutely required for cytokine-stimulated nitric oxide production in macrophages and they suggest that only a small fraction of the total intracellular BH4 pool in macrophages is utilized in the production of fully active nitric oxide synthase.
This article has been cited by other articles:
|
|
 |
|
  A. L. Moens and D. A. Kass Tetrahydrobiopterin and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2439 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Huang, P.-S. Tsai, Y.-F. Kai, C.-H. Yang, and C.-J. Huang Lidocaine inhibition of inducible nitric oxide synthase and cationic amino Acid transporter-2 transcription in activated murine macrophages may involve voltage-sensitive na+ channel. Anesth. Analg., June 1, 2006; 102(6): 1739 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. d'Uscio and Z. S. Katusic Increased vascular biosynthesis of tetrahydrobiopterin in apolipoprotein E-deficient mice Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2466 - H2471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gilchrist, C. Hesslinger, and A. D. Befus Tetrahydrobiopterin, a Critical Factor in the Production and Role of Nitric Oxide in Mast Cells J. Biol. Chem., December 12, 2003; 278(50): 50607 - 50614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Skimming, O. Nasiroglu, C.-J. Huang, C. E. Wood, B. R. Stevens, I. U. L. Haque, P. O. Scumpia, and P. J. Sarcia Dexamethasone suppresses iNOS yet induces GTPCH and CAT-2 mRNA expression in rat lungs Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L484 - L491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Park, H.-J. Na, Y.-G. Kwon, K.-S. Ha, S.-J. Lee, C.-K. Kim, K.-S. Lee, T. Yoneyama, K. Hatakeyama, P. K. M. Kim, et al. Nitric Oxide (NO) Pretreatment Increases Cytokine-induced NO Production in Cultured Rat Hepatocytes by Suppressing GTP Cyclohydrolase I Feedback Inhibitory Protein Level and Promoting Inducible NO Synthase Dimerization J. Biol. Chem., November 27, 2002; 277(49): 47073 - 47079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vasquez-Vivar, D. Duquaine, J. Whitsett, B. Kalyanaraman, and S. Rajagopalan Altered Tetrahydrobiopterin Metabolism in Atherosclerosis: Implications for Use of Oxidized Tetrahydrobiopterin Analogues and Thiol Antioxidants Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1655 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Panda, R. J. Rosenfeld, S. Ghosh, A. L. Meade, E. D. Getzoff, and D. J. Stuehr Distinct Dimer Interaction and Regulation in Nitric-oxide Synthase Types I, II, and III J. Biol. Chem., August 16, 2002; 277(34): 31020 - 31030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hahn, M. R. Trant, M. J. Brownstein, R. A. Harper, S. Milstien, and I. J. Butler Neurologic and Psychiatric Manifestations in a Family With a Mutation in Exon 2 of the Guanosine Triphosphate-Cyclohydrolase Gene Arch Neurol, May 1, 2001; 58(5): 749 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gottsater, I. Anwaar, K.-F. Eriksson, I. Mattiasson, F. Lindgarde, and A. Gottsater Homocysteine Is Related to Neopterin and Endothelin-1 in Plasma of Subjects with Disturbed Glucose Metabolism and Reference Subjects Angiology, June 1, 2000; 51(6): 489 - 497. [Abstract] [PDF]
|
|
|
|
|
|
L. R. Vann, S. Twitty, S. Spiegel, and S. Milstien Divergence in Regulation of Nitric-oxide Synthase and Its Cofactor Tetrahydrobiopterin by Tumor Necrosis Factor-alpha . CERAMIDE POTENTIATES NITRIC OXIDE SYNTHESIS WITHOUT AFFECTING GTP CYCLOHYDROLASE I ACTIVITY J. Biol. Chem., April 28, 2000; 275(18): 13275 - 13281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Anwaar, A. Gottsater, B. Hedblad, B. Palmqvist, I. Mattiasson, and F. Lindgarde Endothelial Derived Vasoactive Factors and Leukocyte Derived Inflammatory Mediators in Subjects with Asymptomatic Atherosclerosis Angiology, December 1, 1998; 49(12): 957 - 966. [Abstract] [PDF]
|
|
|
|
|
|
C. M. Pastor, D. Williams, T. Yoneyama, K. Hatakeyama, S. Singleton, E. Naylor, and T. R. Billiar Competition for Tetrahydrobiopterin between Phenylalanine Hydroxylase and Nitric Oxide Synthase in Rat Liver J. Biol. Chem., October 4, 1996; 271(40): 24534 - 24538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Simmons, D. Ungureanu-Longrois, G. K. Smith, T. W. Smith, and R. A. Kelly Glucocorticoids Regulate Inducible Nitric Oxide Synthase by Inhibiting Tetrahydrobiopterin Synthesis and L-Arginine Transport J. Biol. Chem., September 27, 1996; 271(39): 23928 - 23937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Milstien, H. Jaffe, D. Kowlessur, and T. I. Bonner Purification and Cloning of the GTP Cyclohydrolase I Feedback Regulatory Protein, GFRP J. Biol. Chem., August 16, 1996; 271(33): 19743 - 19751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bencsics, S. R. Wachtel, S. Milstien, K. Hatakeyama, J. B. Becker, and U. J. Kang Double Transduction with GTP Cyclohydrolase I and Tyrosine Hydroxylase Is Necessary for Spontaneous Synthesis of L-DOPA by Primary Fibroblasts J. Neurosci., July 15, 1996; 16(14): 4449 - 4456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saura, D. Perez-Sala, FranciscoJ. Canada, and S. Lamas Role of Tetrahydrobiopterin Availability in the Regulation of Nitric-oxide Synthase Expression in Human Mesangial Cells J. Biol. Chem., June 14, 1996; 271(24): 14290 - 14295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Rodríguez-Crespo, N. C. Gerber, and P. R. O. de Montellano Endothelial Nitric-oxide Synthase J. Biol. Chem., May 10, 1996; 271(19): 11462 - 11467. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. A. Albakri and D. J. Stuehr Intracellular Assembly of Inducible NO Synthase Is Limited by Nitric Oxide-mediated Changes in Heme Insertion and Availability J. Biol. Chem., March 8, 1996; 271(10): 5414 - 5421. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
